Baxter International Inc. (BAX) is a global, multi-billion dollar healthcare company that specializes in delivering critical therapies for people with life-threatening conditions. This Fortune 500 company is based in Deerfield, Illinois, and has a reach in over 100 countries. The company was founded in 1931 by Dr. Donald Baxter, a Los Angeles-based physician, who believed that intravenous therapy could be used effectively outside of the hospital setting.
Baxter International Inc. thrives on a mission to save and sustain lives. Across its portfolio of products and services, Baxter is highly committed to addressing numerous issues faced by patients and healthcare professionals alike. Its expansive product line encompasses renal care, nutritional therapies, pharmaceuticals, surgical products, and several other therapeutic categories. Baxter's most innovative product line is its renal care products, which include dialysis equipment and related disposables.
The company operates through two primary divisions: Hospital Products and Renal. The Hospital Products division comprises fluid systems, injectable pharmaceuticals, inhaled anesthetics, contract manufacturing, and infusion systems. Besides, the division also offers products used in the treatment of acute and chronic medical conditions, such as hemophilia and other bleeding disorders, cancer, kidney disease, and infectious diseases.
The renal division, on the other hand, centers on products and services designed to treat end-stage renal disease (ESRD) and kidney failure. It demonstrates Baxter's commitment to enhancing the quality of patients' lives through innovative technologies that enable at-home peritoneal dialysis treatment.
With a robust track record of growth and innovation, BAX continually expands its product portfolio through strategic acquisitions. Additionally, apart from manufacturing vital health products, Baxter also offers essential services such as training, technical support, and customized patient care. The company's commitment to CSR (Corporate Social Responsibility) is also clearly reflected in its efforts towards improving access to care, fostering tomorrow’s innovation, driving economic development, and strengthening communities around the globe.
One of the company's key strengths is their R&D department, which is dedicated to developing breakthrough technologies in medical treatments, contributing to the company’s leading position in the global healthcare market. With roughly 50,000 employees worldwide, Baxter International Inc. continues to uphold their commitment to operating with the highest standards of integrity, while pursuing initiatives that lead to a sustainable future in healthcare.